United States of America based
Plexium is a biotech startup focused on developing modulators of E3 ligases for the treatment of cancer, immune and neurological diseases. Plexium utilizes DELPhe platform that enables cell-based phenotypic screening of DNA-encoded libraries. Their technology miniaturizes screening to the scale of picoliter volumes.
TechnologiesDNA-Encoded Library Companies Protein Degraders Startups
Posts Mentioning This Company
No pipelines published yet
No services posted yet